Also in this playlist...
This transcript is automatically generated
Every seventy seconds someone in this country develops alzheimer's disease but a medical breakthrough.
May let patients eat to treat.
The disease at -- is a new medical food and it's made by at Sarah joining us now offered exclusive interview processes.
The company founder and CEO keyboard or state -- could have been up boxes Acer.
Thank you for -- this is -- of food.
That helps to stimulate glucose in the system aren't there other more natural ways to do that instead of getting a prescription.
-- -- -- -- Well this is food only in the regulatory sense that is a -- special classification.
At the FDA administered under the orphan drug act.
So for that reason it's called -- medical group but the -- principal ingredient in this product actually generates a special class of chemicals called key towns which address the metabolic defects associated with the disease.
With so -- there's so many bill -- that we that we get that we know we have.
There seems to be more of a portion to areas.
About things that we may get later on down the road the -- divas of the world and that sort of thing are we going to start becoming consumers of things that we.
May not have but may happen to it -- at the marketing idea.
Well that this product is actually target for those who have diagnosis of alzheimer's disease.
We believe that it has potential to address the underlying causes of the disease but -- could be used as a preventative but those clinical studies have not yet been done.
Steve -- -- involved it can you explain a little bit more how this treats the actual disease has.
I I read about your company and I couldn't quite figure out how this.
Attacks any of -- you know models for the mechanism of alzheimer's -- granted there's a lot of question about what those models are but.
This seems more like its treating the symptom not the root cause.
-- I don't think anyone truly has their finger on the the underlying cause of alzheimer's disease but we do know this.
That hypo metabolism -- -- glucose metabolism in the brain.
Is a physiological hallmark of this disease.
It first appears prior to diagnosis of the disease and gets progressively worse as the disease worsens -- also.
We know that it leads to a basically a starvation of the brain which causes the death of neurons which are important and and cognition and memory and in patients.
This is a very well established fundamental principle of alzheimer's.
Disease I have a let me tell you don't hear on one thing I mean you're talking about -- come production and the body.
Why don't you just tell people to go on the Atkins Diet that will stimulate -- tones in the body does not have the same effect.
That this food does that you develop the mean.
-- prescription that your operate like Amazon makes it -- back.
In theory that could work but that -- -- self limiting process and other words you've built they only has certain amount of ability to.
Produce -- talents and they are not it's sufficient level or or or -- length of time to really be therapeutic and alzheimer's patients.
-- you're stuck and mean it seems to me looking at your revenue models -- some kind of a sugar high going on kicker.
I mean to be facetious but what are your revenue models for this drug what do you expect there.
I think -- maybe -- over shooting a little bit.
Well no actually we only predict about ten -- capturing 10% of total sales.
Of alzheimer's products of -- -- -- so that translates are roughly today.
And about 200 million in sales on an annual basis.
We expect -- sales to be approximately.
350 to 500 -- it.
Keyboard shortcut CEO.
We appreciate your taking the time --
Filter by section